Diep · Journal of sleep research 2022 · randomized crossover trial · n=24

Heart rate variability increases following automated acoustic slow wave sleep enhancement.

Cited 14 times in the scientific literature.

Level 2 - randomized trial

Randomized crossover trial

PubMed 35080060 · doi:10.1111/jsr.13545 · record verified 2026-08-29

What was done

In a randomized crossover trial under controlled conditions, 24 healthy middle-aged males (mean age 39.92 ± 4.15 years) received closed-loop brain state-dependent acoustic stimulation (auditory tones) and a sham condition (no tones), separated by a 1-week washout period. Heart rate variability parameters (including high-frequency power and SDNN) and slow-wave activity were evaluated for the whole night and across the first three sleep cycles.

What was found

Slow-wave activity increased following acoustic stimulation compared to sham. There was a statistically significant increase in high-frequency power and standard deviation of normalized RR-intervals (SDNN) during acoustic stimulation compared with sham (p < 0.05), driven specifically by changes during N3 sleep. Specific numerical values, effect sizes, and confidence intervals were not reported in the abstract.

Why it matters

This study demonstrates that non-invasive closed-loop acoustic stimulation designed to enhance deep sleep can acutely modulate autonomic cardiovascular control in middle-aged adults.

Limits

The study was small (n = 24) and limited to healthy middle-aged men, precluding generalization to females, older populations, or clinical cohorts. The abstract provides p-values without absolute values, effect sizes, or confidence intervals, and only assesses acute single-night effects under laboratory conditions rather than sustained home use or clinical cardiovascular outcomes.

Cited by